Wall 
MRK - Merck
Annual data, 1996 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Other companies
AMGN
Amgen
Data since 1996
$218 BMarket cap
$38 BRevenue TTM
$10 BIncome TTM
7.2%Cap CAGR 10Y
+1,414%Cap total growth
JNJ
Johnson & Johnson
Data since 1996
$617 BMarket cap
$98 BRevenue TTM
$26 BIncome TTM
7.0%Cap CAGR 10Y
+831%Cap total growth
RO.SW
Roche
Data since 1998
$342 BMarket cap
–Revenue TTM
–Income TTM
5.8%Cap CAGR 10Y
+95%Cap total growth
NVS
Novartis
Data since 1998
$268 BMarket cap
$57 BRevenue TTM
$16 BIncome TTM
4.5%Cap CAGR 10Y
+100%Cap total growth
ABBV
AbbVie
Data since 2010
$464 BMarket cap
$64 BRevenue TTM
$9 BIncome TTM
16.4%Cap CAGR 10Y
+760%Cap total growth
AZN
AstraZeneca
Data since 1996
$243 BMarket cap
$61 BRevenue TTM
$14 BIncome TTM
13.4%Cap CAGR 10Y
+818%Cap total growth
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown.